EE729 Early Intervention With Biosimilars Compared With Leflunomide in Established Rheumatoid Arthritis: A Cost-Effectiveness Analysis in Hong Kong
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.994
https://www.valueinhealthjournal.com/article/S1098-3015(23)04124-4/fulltext
Section Title :
Section Order :
10490
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04124-4&doi=10.1016/j.jval.2023.09.994